The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, C. B.
Right arrow Articles by Allen, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, C. B.
Right arrow Articles by Allen, P. M.
The Journal of Immunology, 1998, 161: 128-137.
Copyright © 1998 by The American Association of Immunologists

In Vivo Expression of a TCR Antagonist: T Cells Escape Central Tolerance But Are Antagonized in the Periphery1

Calvin B. Williams2,*, Karine Vidal{dagger}, David Donermeyer{dagger}, Daniel A. Peterson{dagger}, J. Michael White{dagger} and Paul M. Allen3,{dagger}

Departments of * Pediatrics and {dagger} Pathology, Center for Immunology, Washington University School of Medicine, St. Louis, MO 63110

Transgenic 3.L2 T cells are stimulated by Hb(64–76)/I-Ek and are positively selected on I-Ek plus self-peptides. To this pool of self-peptides we have added a single, well-defined 3.L2 TCR antagonist (A72) in vivo. We find that mice expressing both the 3.L2 TCR and A72 have a minimal loss of T cells expressing the clonotypic TCR in the thymus and spleen. Importantly, the proliferative response of 3.L2 x A72 splenocytes is significantly reduced compared with splenocytes from 3.L2 mice. This reduced response can be attributed to peripheral antagonism. Thus we have identified a new class of self-ligands whose predominant effect is constitutive peripheral antagonism rather than negative selection. The net effect of these ligands is to avoid potential self-reactivity while maintaining as large a repertoire as possible.




This article has been cited by other articles:


Home page
J. Immunol.Home page
L. M. Relland, M. K. Mishra, D. Haribhai, B. Edwards, J. Ziegelbauer, and C. B. Williams
Affinity-Based Selection of Regulatory T Cells Occurs Independent of Agonist-Mediated Induction of Foxp3 Expression
J. Immunol., February 1, 2009; 182(3): 1341 - 1350.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Fujimoto, C.-R. Yu, G. Shi, B. P. Vistica, E. F. Wawrousek, D. M. Klinman, C.-C. Chan, C. E. Egwuagu, and I. Gery
Pertussis Toxin Is Superior to TLR Ligands in Enhancing Pathogenic Autoimmunity, Targeted at a Neo-Self Antigen, by Triggering Robust Expansion of Th1 Cells and Their Cytokine Production
J. Immunol., November 15, 2006; 177(10): 6896 - 6903.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H. Kao and P. M. Allen
An antagonist peptide mediates positive selection and CD4 lineage commitment of MHC class II-restricted T cells in the absence of CD4
J. Exp. Med., January 3, 2005; 201(1): 149 - 158.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
D. Haribhai, B. Edwards, M. L. Williams, and C. B. Williams
Functional Reprogramming of the Primary Immune Response by T Cell Receptor Antagonism
J. Exp. Med., December 6, 2004; 200(11): 1371 - 1382.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
F. F. Shih, L. Mandik-Nayak, B. T. Wipke, and P. M. Allen
Massive Thymic Deletion Results in Systemic Autoimmunity through Elimination of CD4+ CD25+ T Regulatory Cells
J. Exp. Med., February 2, 2004; 199(3): 323 - 335.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. Murphy, J. Yu, Q. Jiao, M. Lin, T. Chitnis, and M. H. Sayegh
A Novel Mechanism for the Immunomodulatory Functions of Class II MHC-Derived Peptides
J. Am. Soc. Nephrol., April 1, 2003; 14(4): 1053 - 1065.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Haribhai, D. Engle, M. Meyer, D. Donermeyer, J. M. White, and C. B. Williams
A Threshold for Central T Cell Tolerance to an Inducible Serum Protein
J. Immunol., March 15, 2003; 170(6): 3007 - 3014.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. R. Santori, S. M. Brown, Y. Lu, T. A. Neubert, and S. Vukmanovic
Cutting Edge: Positive Selection Induced by a Self-Peptide with TCR Antagonist Activity
J. Immunol., December 1, 2001; 167(11): 6092 - 6095.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Raman, F. Blaeser, N. Ho, D. L. Engle, C. B. Williams, and T. A. Chatila
Requirement for Ca2+/Calmodulin-Dependent Kinase Type IV/Gr in Setting the Thymocyte Selection Threshold
J. Immunol., December 1, 2001; 167(11): 6270 - 6278.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. R. Santori, I. Arsov, and S. Vukmanovic
Modulation of CD8+ T Cell Response to Antigen by the Levels of Self MHC Class I
J. Immunol., May 1, 2001; 166(9): 5416 - 5421.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C. B. Williams, D. L. Engle, G. J. Kersh, J. Michael White, and P. M. Allen
A Kinetic Threshold between Negative and Positive Selection Based on the Longevity of the T Cell Receptor-Ligand Complex
J. Exp. Med., May 17, 1999; 189(10): 1531 - 1544.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. R. Plas, C. B. Williams, G. J. Kersh, L. S. White, J. M. White, S. Paust, T. Ulyanova, P. M. Allen, and M. L. Thomas
Cutting Edge: The Tyrosine Phosphatase SHP-1 Regulates Thymocyte Positive Selection
J. Immunol., May 15, 1999; 162(10): 5680 - 5684.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. C. Jameson
T cell receptor antagonism in vivo, at last
PNAS, November 24, 1998; 95(24): 14001 - 14002.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Basu, C. B. Williams, and P. M. Allen
In vivo antagonism of a T cell response by an endogenously expressed ligand
PNAS, November 24, 1998; 95(24): 14332 - 14336.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.